- Home
- PMEC vs CPIX Comparison
PMEC vs CPIX Comparison
Compare PMEC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- CPIX
- Stock Information
- Founded
- PMEC 1984
- CPIX 1999
- Country
- PMEC Singapore
- CPIX United States
- Employees
- PMEC N/A
- CPIX N/A
- Industry
- PMEC
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- CPIX Health Care
- Exchange
- PMEC Nasdaq
- CPIX Nasdaq
- Market Cap
- PMEC 46.1M
- CPIX 40.1M
- IPO Year
- PMEC 2023
- CPIX 2009
- Fundamental
- Price
- PMEC N/A
- CPIX $3.15
- Analyst Decision
- PMEC
- CPIX
- Analyst Count
- PMEC 0
- CPIX 0
- Target Price
- PMEC N/A
- CPIX N/A
- AVG Volume (30 Days)
- PMEC 52.6K
- CPIX 110.2K
- Earning Date
- PMEC 01-01-0001
- CPIX 08-05-2025
- Dividend Yield
- PMEC N/A
- CPIX N/A
- EPS Growth
- PMEC N/A
- CPIX N/A
- EPS
- PMEC N/A
- CPIX N/A
- Revenue
- PMEC $74,310,000.00
- CPIX $41,083,299.00
- Revenue This Year
- PMEC N/A
- CPIX N/A
- Revenue Next Year
- PMEC N/A
- CPIX N/A
- P/E Ratio
- PMEC N/A
- CPIX N/A
- Revenue Growth
- PMEC 3.94
- CPIX 5.82
- 52 Week Low
- PMEC $0.49
- CPIX $1.04
- 52 Week High
- PMEC $1.49
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- PMEC 68.28
- CPIX 37.09
- Support Level
- PMEC $1.26
- CPIX $2.52
- Resistance Level
- PMEC $1.46
- CPIX $3.76
- Average True Range (ATR)
- PMEC 0.12
- CPIX 0.59
- MACD
- PMEC 0.03
- CPIX -0.14
- Stochastic Oscillator
- PMEC 97.96
- CPIX 19.39
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.